Your browser doesn't support javascript.
loading
Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.
de Niet, Annikki; Jansen, Louis; Zaaijer, Hans L; Klause, Ursula; Takkenberg, Bart; Janssen, Harry L A; Chu, Tom; Petric, Rosemary; Reesink, Hendrik W.
Affiliation
  • de Niet A; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands. a.deniet@amc.nl.
Antivir Ther ; 19(3): 259-67, 2014.
Article in En | MEDLINE | ID: mdl-24256626

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Adenine / Interferon-alpha / Hepatitis B, Chronic / Organophosphonates / Hepatitis B Antibodies / Hepatitis B e Antigens / Hepatitis B Surface Antigens / Antigen-Antibody Complex Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Antivir Ther Journal subject: TERAPIA POR MEDICAMENTOS / VIROLOGIA Year: 2014 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Adenine / Interferon-alpha / Hepatitis B, Chronic / Organophosphonates / Hepatitis B Antibodies / Hepatitis B e Antigens / Hepatitis B Surface Antigens / Antigen-Antibody Complex Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Antivir Ther Journal subject: TERAPIA POR MEDICAMENTOS / VIROLOGIA Year: 2014 Type: Article Affiliation country: Netherlands